SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Lemon Tree Hotels, Sun Pharmaceutical Industries and MPS to see some action today

Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524715 | NSE: SUNPHARMA

31 May 2022 Evaluate

Lemon Tree Hotels has signed a License Agreement for a 40 room hotel at Chirang, Assam under the Company's brand 'Keys Select, by Lemon Tree Hotels'. The hotel is expected to be operational by June, 2026. Carnation Hotels, a subsidiary and the hotel management arm of the Company will be operating this hotel.

Sun Pharmaceutical Industries is expecting high single-digit top-line growth in the current financial year with all its business verticals well placed to lead the charge. The company, which posted revenues of Rs 38,426 crore in FY22, aims to invest 7-8 per cent of sales in the R&D front in the ongoing fiscal.

To serve the needs of premium households who want the next generational connectivity and entertainment experience, Bharti Airtel (Airtel) has once again raised the bar in the home broadband segment with the launch of three new all-in-one plans built for the evolving entertainment needs of today’s connected homes.

MPS has completed the acquisition of 100% of the issued and paid up equity share capital of E.I. Designs through MPS Interactive Systems (MPSI), a wholly owned subsidiary of the Company by executing a share purchase agreement (Share Purchase Agreement). The shares held by the shareholders of E.I. Design have been purchased by MPSI by executing a share purchase agreement at a consideration of Rs 40 crore on a cash-free, debt-free basis.

Lux Industries has received an approval for capital expenditure of Rs 50 crore for capital expansion plans at Ludhiana and for other Capital expenditure of the Company. The company has participated in e-auction organized by Punjab Small Industries & Export Corporation and has been allotted plot No. A-10, Phase V, Focal point, Ludhiana measuring about 34,067 sq. yards.

Jubilant FoodWorks’ wholly owned subsidiary-- Jubilant Foodworks Netherlands B.V. (JFN) has increased its stake in DP Eurasia N.V. (DPEU) through various on-market purchases. As on May 29, 2022, JFN is holding 62,067,676 ordinary shares in DPEU representing 42.70% of its issued share capital.

Axis Bank has started to reap the benefits of its strategy to grow organically alongside strong partnerships to fuel growth in the credit cards business, raking in the highest ever acquisition in the March quarter. Buoyed by the growth, the bank is eyeing capturing one-fifth of the credit card market in the medium term. The fourth-largest private sector bank clocked the highest ever quarterly growth with over 1.1 million credit card acquisitions in the March quarter of 2021-22.

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1675.20
Dr. Reddys Lab	1235.40
Cipla	1238.30
Zydus Lifesciences	942.55
Lupin	2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Lemon Tree Hotels, Sun Pharmaceutical Industries and MPS to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.